Serum neurofilament light chain (sNfL) has emerged as a promising biomarker for various neurological conditions, including peripheral neuropathy (PN) [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11]. This evidence concerns the gene NEFL and peripheral neuropathy.